GSA Capital Partners’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-52,700
| Closed | -$679K | – | 1857 |
|
|
2019
Q1 | $679K | Sell |
52,700
-541
| -1% | -$6.97K | 0.07% | 510 |
|
|
2018
Q4 | $809K | Sell |
53,241
-32,003
| -38% | -$486K | 0.09% | 313 |
|
|
2018
Q3 | $1.71M | Buy |
85,244
+29,100
| +52% | +$582K | 0.09% | 330 |
|
|
2018
Q2 | $1.1M | Buy |
+56,144
| New | +$1.1M | 0.05% | 700 |
|
|
2018
Q1 | – | Sell |
-100,561
| Closed | -$1.33M | – | 1919 |
|
|
2017
Q4 | $1.33M | Sell |
100,561
-32,709
| -25% | -$433K | 0.08% | 426 |
|
|
2017
Q3 | $2.46M | Buy |
133,270
+40,270
| +43% | +$743K | 0.17% | 92 |
|
|
2017
Q2 | $1.71M | Buy |
93,000
+46,200
| +99% | +$850K | 0.11% | 217 |
|
|
2017
Q1 | $1.06M | Buy |
46,800
+14,092
| +43% | +$318K | 0.06% | 607 |
|
|
2016
Q4 | $1.14M | Sell |
32,708
-1,152
| -3% | -$40.1K | 0.07% | 493 |
|
|
2016
Q3 | $830K | Buy |
33,860
+24,300
| +254% | +$596K | 0.04% | 724 |
|
|
2016
Q2 | $229K | Sell |
9,560
-1,840
| -16% | -$44.1K | 0.01% | 1514 |
|
|
2016
Q1 | $267K | Buy |
+11,400
| New | +$267K | 0.02% | 1360 |
|
|
2015
Q4 | – | Sell |
-28,465
| Closed | -$1.13M | – | 2043 |
|
|
2015
Q3 | $1.13M | Buy |
28,465
+1,567
| +6% | +$62.3K | 0.06% | 554 |
|
|
2015
Q2 | $1.86M | Buy |
26,898
+11,988
| +80% | +$828K | 0.07% | 422 |
|
|
2015
Q1 | $815K | Buy |
14,910
+8,014
| +116% | +$438K | 0.03% | 1034 |
|
|
2014
Q4 | $294K | Buy |
+6,896
| New | +$294K | 0.02% | 1275 |
|
|
2014
Q2 | – | Sell |
-14,615
| Closed | -$283K | – | 2021 |
|
|
2014
Q1 | $283K | Sell |
14,615
-300
| -2% | -$5.81K | 0.02% | 1171 |
|
|
2013
Q4 | $362K | Buy |
+14,915
| New | +$362K | 0.03% | 1075 |
|